✦ LIBER ✦
The immunomodulatory drug lenalidomide restores a vitamin D sensitive phenotype to the vitamin D resistant breast cancer cell line MDA-MB-231 through inhibition of BCL-2: potential for breast cancer therapeutics
✍ Scribed by Carole Brosseau; Kay Colston; Angus George Dalgleish; Christine Galustian
- Publisher
- Springer
- Year
- 2011
- Tongue
- English
- Weight
- 498 KB
- Volume
- 17
- Category
- Article
- ISSN
- 1360-8185
No coin nor oath required. For personal study only.